Pitch: US startup producing egg proteins via precision fermentation

Source: The Every Company

ID card

• HQ: US
• Founded: 2015
• Funding: $296.8M
• Last Funding: $55M Series D (11/2025)
• Corporate investors: Minerva Foods, Rich Products, Ingredion
• Partnerships: Vivici & the Abu Dhabi Investment Office, Landish Foods, The Vegetarian Butcher, Ingredion, AB InBev
• Technology/product: precision-fermented egg proteins
• Competitors: Onego Bio (Finland, which we mentioned last year in a scouting ID card) precision-fermented ovalbumin => very limited number of players
• Regulation: FDA GRAS “no questions” status for its precision-fermented egg white protein (GRN 1104, 2022) + submitted applications under the Novel Foods process in the EU and the UK

More insights

• The Every Co offers two ingredients:
  • OvoPro: recombinant ovalbumin that replaces egg-white functionality, positioned as cost-competitive or even cheaper on a cost-in-use basis vs commodity eggs, relevant amid avian flu-driven volatility.
  • OvoBoost: highly soluble, taste- and texture-neutral protein ingredient designed to fortify products (coffee, juices, syrups, baked goods).
• It claims a 18-month shelf life for its egg proteins in powder form, without the need for a cold chain.
• Production runs at commercial scale with a European manufacturing partner (metric tonnes/month), with plans to double capacity.
• The patent dispute with Onego Bio in 2025 highlights intensifying competition around precision-fermented ovalbumin, but also acts as a barrier for new entrants (the two players have patents creating a moat around this topic).

For Symrise

Why did we select the startup? The Every Co has demonstrated industrial-scale precision fermentation delivering functional egg white proteins, a rare feat in the precision fermentation space. Now, the question is about how to integrate this protein into ingredient lists, in which applications…

Why now?

The momentum is strong due to the egg shortages in the US, and now in parts of Europe. From the startup point of view, with the Series D funding, as well as the announcement of a large UAE-based 4M-litre facility, it has an ability to scale. As Ingredion is already invested in Every Co, looking at its direct competitor Onego could be relevant for Symrise.

Source: The Every Company